NCT00660699View on ClinicalTrials.gov

A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2012

Conditions
Cholangiocarcinoma CancerGallbladder CancerPancreatic CancerAmpullary Cancer
Interventions
DRUG

Gemcitabine

DRUG

Docetaxel

RADIATION

Radiation

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT00660699 - A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers | Biotech Hunter | Biotech Hunter